Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis

@inproceedings{Iwamoto2008ComparisonOE,
  title={Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis},
  author={Jun Iwamoto and Yoshihiro Sato and Mitsuyoshi Uzawa and Tsuyoshi Takeda and Hideo Matsumoto},
  booktitle={Yonsei medical journal},
  year={2008}
}
  • Jun Iwamoto, Yoshihiro Sato, +2 authors Hideo Matsumoto
  • Published in Yonsei medical journal 2008
  • Medicine
  • PURPOSE To compare the effects of alendronate and raloxifene on lumbar bone mineral density (BMD), bone turnover, and lipid metabolism in elderly women with osteoporosis. SUBJECTS AND METHODS One hundred twenty-two postmenopausal women with osteoporosis (mean age: 69.4 years) were randomly divided into 2 groups of 61 patients: the alendronate group and the raloxifene group. BMD of the lumbar spine, urinary level of cross-linked N-terminal telopeptides of type I collagen (NTX), and serum… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 27 CITATIONS

    Alendronate versus Raloxifene for Postmenopausal Women: A Meta-Analysis of Seven Head-to-Head Randomized Controlled Trials

    VIEW 10 EXCERPTS
    CITES BACKGROUND & RESULTS
    HIGHLY INFLUENCED

    Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)

    VIEW 4 EXCERPTS
    CITES BACKGROUND & RESULTS
    HIGHLY INFLUENCED

    CLINICAL EVALUATION OF COST EFFICACY OF DRUGS FOR TREATMENT OF OSTEOPOROSIS: A META-ANALYSIS.

    • Stewart G. Albert, Supraja Reddy
    • Medicine
    • Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
    • 2017

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 32 REFERENCES

    Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.